Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Janice Piatt, Phoenix Children's Hospital
ClinicalTrials.gov Identifier:
NCT00940771
First received: July 15, 2009
Last updated: October 21, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)